Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are patients informed when they consent to ERCP?

Sinead O'Sullivan1, Craig Crippen, Terry Ponich

  • 1Division of Gastroenterlogy, University of Western Ontario, London, Canada.

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|April 4, 2002
PubMed
Summary

Informed consent for endoscopic retrograde cholangiopancreatography (ERCP) in Ontario shows significant variability. Standardized guidelines are needed to ensure comprehensive patient understanding and reduce liability risks for ERCP procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.

Pharmacogenetics and genomics·2026
Same author

Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study.

Clinical and translational gastroenterology·2026
Same author

IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.

Alimentary pharmacology & therapeutics·2025
Same author

Day 3 Oxford criteria predict steroid non-response for acute severe ulcerative colitis in the post biologic era.

Journal of Crohn's & colitis·2025
Same author

Genotyping as Part of Routine Clinical Care-The Outcomes for a Large Paediatric Vascular Anomaly Cohort.

American journal of medical genetics. Part A·2025
Same author

Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments.

United European gastroenterology journal·2024

Area of Science:

  • Gastroenterology
  • Medical Ethics
  • Patient Safety

Background:

  • Existing guidelines for informed consent in endoscopic retrograde cholangiopancreatography (ERCP) are limited, with only the British Society of Gastroenterology offering inclusive recommendations.
  • Prior research indicates inconsistencies in the information provided to patients undergoing ERCP procedures.

Purpose of the Study:

  • To investigate and analyze the current practices of informed consent for patients undergoing ERCP within the province of Ontario.
  • To identify variations in how endoscopists discuss risks, benefits, and alternatives associated with ERCP.

Main Methods:

  • A self-report questionnaire was distributed to endoscopists performing ERCP in Ontario.
  • The survey assessed the communication of risks (pancreatitis, bleeding, perforation, infection, allergies, death), benefits, alternatives, consent methods (written vs. verbal), and modifications for elderly patients (over 75).
Keywords:
Empirical ApproachProfessional Patient Relationship

Related Experiment Videos

Main Results:

  • A 40% response rate was achieved from 82 distributed surveys.
  • Written consent was obtained by 94% of respondents, while 6% used verbal consent.
  • Significant variability was observed in the disclosure of risks, with pancreatitis (91%) and bleeding (88%) frequently mentioned, but death (73% rarely/never) and contrast allergies (24% always) less consistently discussed. Disclosure of diagnostic/therapeutic failure also varied.

Conclusions:

  • There is considerable variability in the essential information conveyed to patients during the informed consent process for ERCP.
  • Implementing standardized, ERCP-specific informed consent guidelines could improve patient comprehension and mitigate legal risks for healthcare providers.